QR-Code

METformin for the MINimization of Geographic Atrophy Progression (METforMIN): A Randomized Trial

Purpose: Metformin use has been associated with a decreased risk of age-related macular degeneration (AMD) progression in observational studies. We aimed to evaluate the efficacy of oral metformin for slowing geographic atrophy (GA) progression. Design: Parallel-group, multicenter, randomized phase...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Liangbo Linus Shen, MD, Jeremy D. Keenan, MD, MPH, Noor Chahal, BS, Abu Tahir Taha, BS, Jasmeet Saroya, BS, Chu Jian Ma, MD, Mengyuan Sun, PhD, Daphne Yang, BS, Catherine Psaras, BA, Jacquelyn Callander, MD, Christina Flaxel, MD, Amani A. Fawzi, MD, Thomas K. Schlesinger, MD, PhD, Robert W. Wong, MD, Loh-Shan Bryan Leung, MD, Alexander M. Eaton, MD, Nathan C. Steinle, MD, David G. Telander, MD, Armin R. Afshar, MD, Melissa D. Neuwelt, MD, Jennifer I. Lim, MD, Glenn C. Yiu, MD, PhD, Jay M. Stewart, MD
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2024-05-01
Schriftenreihe:Ophthalmology Science
Schlagworte:
Age-related macular degeneration
Geographic atrophy
Metformin
Randomized controlled trial
Online-Zugang:http://www.sciencedirect.com/science/article/pii/S2666914523001720
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge